MedTrace Logo

Effect of Type II Diabetes Mellitus With Neuropathy on the Clinical Use of Rocuronium

NCT03737942 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2018-11-20

No results posted yet for this study

Summary

International Diabetes Federation estimates that there are now 415 million adults aged 20-79 with diabetes mellitus worldwide. By 2040 this will rise to 640 million. Although diabetes mellitus is highly prevalent in our environment and one of the most important challenges of modern medicine, only a handful of studies have examined the neuromuscular function in diabetic patients. The shortage of publications in this area is still more surprising if we consider that the neuromuscular blockers are one of the pillars in the administration of general anesthesia. Neuromuscular blockers during surgery are used in tracheal intubation and to improve surgical conditions.

Conditions

  • Neuromuscular Transmission Disorder
  • Diabetes Mellitus, Type 2

Interventions

DEVICE

monitoring of neuromuscular function

started by percutaneous stimulation of the cubital nerve at the wrist level

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ghada Abo Elfadl, M.D · Assiut University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-15
Primary Completion
2019-01-15
Completion
2019-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03737942 on ClinicalTrials.gov